<SUBMISSION>
<SECRELEASE-DATETIME> 20140205-174238 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20140205-174238 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20140205-174155 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001181431-14-005279
<TYPE> 3
<PUBLIC-DOCUMENT-COUNT> 2
<PERIOD> 20140205
<FILING-DATE> 20140205
<DATE-OF-FILING-DATE-CHANGE> 20140205
|
<ISSUER>
<COMPANY-DATA>
<CONFORMED-NAME> ARATANA THERAPEUTICS, INC.
<CIK> 0001509190
<ASSIGNED-SIC> 2834
<IRS-NUMBER> 383826477 ⇒ 38-3826477 or 383-82-6477
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<BUSINESS-ADDRESS>
<STREET1> 1901 OLATHE BOULEVARD
<CITY> KANSAS CITY
<STATE> KS
<ZIP> 66103
<PHONE> 913.951.2130
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 1901 OLATHE BOULEVARD
<CITY> KANSAS CITY
<STATE> KS
<ZIP> 66103
</MAIL-ADDRESS>
</ISSUER>
|
<REPORTING-OWNER>
<OWNER-DATA>
<CONFORMED-NAME> Brege Laura
<CIK> 0001365619
</OWNER-DATA>
<FILING-VALUES>
<FORM-TYPE> 3
<ACT> 34
<FILE-NUMBER> 001-35952
<FILM-NUMBER> 14577218
</FILING-VALUES>
<MAIL-ADDRESS>
<STREET1> C/O ONYX PHARMACEUTICALS, INC.
<STREET2> 2100 POWELL STREET
<CITY> EMERYVILLE
<STATE> CA
<ZIP> 94608
</MAIL-ADDRESS>
</REPORTING-OWNER>
|
<DOCUMENT>
<TYPE> 3
<SEQUENCE> 1
<FILENAME> rrd400538.xml
<DESCRIPTION> BREGE F3
<TEXT>
<XML>
<?xml version="1.0"?>
Show <XML>: 47 lines (widest: 92 characters) - 2K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-24.1
<SEQUENCE> 2
<FILENAME> rrd360446_408603.htm
<DESCRIPTION> POWER OF ATTORNEY
<TEXT>
<HTML>
Show <HTML>: 69 lines (widest: 118 characters) - 4K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
